Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Alberta Health services

Status: Unknown

Conditions: Hematologic Malignancy

Treatments: Drug: intravenous busulfan

Study type: Interventional

Funder types: Other

Identifiers

NCT00156858

717905172

10156

Details and patient eligibility

About

A study of pharmacokinetics of daily intravenous busulfan

Full description

A study of pharmacokinetics of daily intravenous busulfan

Enrollment: 200 estimated patients

Sex: All

Ages: Under 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing transplantation

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)